Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-03-21 to 2023-03-22
Current total value of award: $11035.39
Description: 4560327576!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML